Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A novel player in inflammation and cancer: the deubiquitinase CYLD controls HCC development.

× No keyword cloud information.

5 in total

1. Downregulation of miR-362-5p inhibits proliferation, migration and invasion of human breast cancer MCF7 cells.

Authors: Fang Ni; Zhaohua Gui; Qiang Guo; Zhongqian Hu; Xinyi Wang; Danlei Chen; Siying Wang
Journal: Oncol Lett Date: 2015-12-03 Impact factor: 2.967

2. MiR-130b inhibits proliferation and induces apoptosis of gastric cancer cells via CYLD.

Authors: Baoyou Sun; Lei Li; Wendong Ma; Shikang Wang; Chunjin Huang
Journal: Tumour Biol Date: 2015-12-28

3. STK4 regulates TLR pathways and protects against chronic inflammation-related hepatocellular carcinoma.

Authors: Weiyun Li; Jun Xiao; Xin Zhou; Ming Xu; Chaobo Hu; Xiaoyan Xu; Yao Lu; Chang Liu; Shengjie Xue; Lei Nie; Haibin Zhang; Zhiqi Li; Yanbo Zhang; Fu Ji; Lijian Hui; Wufan Tao; Bin Wei; Hongyan Wang
Journal: J Clin Invest Date: 2015-10-12 Impact factor: 14.808

4. miR‑197‑3p‑induced downregulation of lysine 63 deubiquitinase promotes cell proliferation and inhibits cell apoptosis in lung adenocarcinoma cell lines.

Authors: Yang Chen; Chunlu Yang
Journal: Mol Med Rep Date: 2017-12-20 Impact factor: 2.952

Review 5. The Key Role of microRNAs in Initiation and Progression of Hepatocellular Carcinoma.

Authors: Suliman Khan; De-Yu Zhang; Ji-Yu Zhang; Mian Khizar Hayat; Jingli Ren; Safyan Nasir; Muhammad Fawad; Qian Bai
Journal: Front Oncol Date: 2022-07-18 Impact factor: 5.738

5 in total